Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $93.03 USD
Change Today -1.96 / -2.06%
Volume 3.8M
ABC On Other Exchanges
New York
As of 8:04 PM 10/6/15 All times are local (Market data is delayed by at least 15 minutes).

amerisourcebergen corp (ABC) Snapshot

Previous Close
Day High
Day Low
52 Week High
04/30/15 - $120.68
52 Week Low
10/16/14 - $74.32
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield

amerisourcebergen corp (ABC) Details

AmerisourceBergen Corporation sources and distributes pharmaceutical products to healthcare providers, pharmaceutical and biotech manufacturers, and specialty drug patients in the United States and internationally. Its Pharmaceutical Distribution segment distributes brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to various healthcare providers, including acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and other alternate site pharmacies, and other customers. It also provides pharmacy management, staffing, and other consulting services; scalable automated pharmacy dispensing equipment; medication and supply dispensing cabinets; and packaging solutions to institutional and retail healthcare providers. In addition, this segment provides pharmaceutical distribution and other services primarily to physician practices in various disease states, such as oncology, as well as to other healthcare providers, including dialysis clinics; distributes plasma and other blood products, injectible pharmaceuticals, and vaccines; and third party logistics and outcomes research, and other services for biotechnology and other pharmaceutical manufacturers. The company’s Other segment provides commercialization support services, including reimbursement support programs, outcomes research, contract field staffing, patient assistance and co-pay assistance programs, adherence programs, risk mitigation services, and other market access programs to pharmaceutical and biotechnology manufacturers; and specialty transportation and logistics services for the biopharmaceutical industry. AmerisourceBergen Corporation markets its products and services through independent sales forces and marketing organizations. The company was founded in 1985 and is headquartered in Chesterbrook, Pennsylvania.

13,000 Employees
Last Reported Date: 11/25/14
Founded in 1985

amerisourcebergen corp (ABC) Top Compensated Officers

Chief Executive Officer, President, Director ...
Total Annual Compensation: $1.2M
Chief Financial Officer and Executive Vice Pr...
Total Annual Compensation: $632.7K
Executive Vice President of Retail Strategy a...
Total Annual Compensation: $626.5K
Executive Vice President and President of Ame...
Total Annual Compensation: $515.0K
Executive Vice President and General Counsel
Total Annual Compensation: $584.1K
Compensation as of Fiscal Year 2014.

amerisourcebergen corp (ABC) Key Developments

AmerisourceBergen Mulls Acquisitions

AmerisourceBergen Corporation (NYSE:ABC) is seeking acquisitions. Steven H. Collis, President and Chief Executive Officer of AmerisourceBergen, said, “With our cash flow generation, we have tremendous flexibility to mitigate the remaining impact of the warrants either through share repurchases, hedging activities, or strategic acquisitions."

AmerisourceBergen Corporation Elects D. Mark Durcan to its Board of Directors

AmerisourceBergen Corporation announced that its Board of Directors has elected D. Mark Durcan, 54, to its Board of Directors, effective immediately. Mr. Durcan fills the vacancy created by Edward E. Hagenlocker’s retirement at the annual meeting of stockholders on March 5, 2015. Mr. Durcan is currently the Chief Executive Officer and a director of Micron Technology Inc. Mr. Durcan, a 30-year veteran of Micron, has served as Chief Executive Officer and a director since February 2012. Mr. Durcan currently serves on the Board of Directors of Freescale Semiconductor Ltd., the Semiconductor Industry Association Board and the Tech CEO Council. He is the Chairman of the Micron Technology Foundation Inc.

AmerisourceBergen Corporation Presents at Morgan Stanley Global Healthcare Conference - New York, Sep-16-2015 11:05 AM

AmerisourceBergen Corporation Presents at Morgan Stanley Global Healthcare Conference - New York, Sep-16-2015 11:05 AM. Venue: The Grand Hyatt New York, 109 East 42nd Street, New York, New York, United States. Speakers: Steven H. Collis, Chief Executive Officer, President, Director and Member of Executive Committee.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ABC:US $93.03 USD -1.96

ABC Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Baxter International Inc $32.27 USD -1.03
Cardinal Health Inc $78.11 USD -1.44
Henry Schein Inc $136.62 USD -1.59
McKesson Corp $184.00 USD -5.71
Tractor Supply Co $86.57 USD -1.84
View Industry Companies

Industry Analysis


Industry Average

Valuation ABC Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 0.2x
Price/Book 13.1x
Price/Cash Flow NM Not Meaningful
TEV/Sales 0.1x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact AMERISOURCEBERGEN CORP, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at